Notice of Results
Chi-Med to Announce 2020 Final Results
Hong Kong, Shanghai, & Florham Park, NJ: Wednesday, February 3, 2021: Hutchison China MediTech Limited (¡Chi-Med¡) (Nasdaq/AIM: HCM) will be announcing its final results for the year ended December 31, 2020 on Thursday, March 4 , 2021 at 12:00 noon Greenwich Mean Time (GMT) / 8:00 pm Hong Kong Time (HKT) / 7:00 am Eastern Standard Time (EST).
Analysts and investors are invited to join a conference call and audio webcast presentation with Q&A, conducted by Chi-Med management.
The conference call and audio webcast will take place at 1:00 pm GMT / 9:00 pm HKT / 8 :00 am EST on Thursday, March 4, 2021 and will be webcast live via the company website at www.chi-med.com/investors/event-information/ . The presentation will be available for downloading before the conference call begins. Details of the conference call dial-in will be provided in the financial results announcement and on the company website. A replay will also be available on the website shortly after the event.
About Chi-Med
Chi-Med (Nasdaq/AIM: HCM) is an innovative, commercial-stage, biopharmaceutical company committed, over the past twenty years, to the discovery and global development of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. It has a portfolio of nine cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. For more information, please visit: www.chi-med.com .
CONTACTS
|
Investor Enquiries |
|
|
Mark Lee, Senior Vice President |
+852 2121 8200 |
|
Annie Cheng, Vice President |
+1 (973) 567 3786 |
|
|
|
|
Media Enquiries |
|
|
Americas - Brad Miles, Solebury Trout |
+1
(917)
570
7340
(Mobile)
|
|
Europe - Ben Atwell / Alex Shaw, FTI Consulting |
+44
20
3727
1030 / +44
7771
913
902
(Mobile) /
+44 7779 545 055 (Mobile)
|
|
Asia - Joseph Chi Lo / Zhou Yi, Brunswick |
+852 9850 5033 (Mobile), jlo@brunswickgroup.com / +852 97 83 6894 (Mobile), y zhou@brunswickgroup.com |
|
|
|
|
Nominated Advisor |
|
|
Freddy Crossley / Atholl Tweedie, Panmure Gordon (UK) Limited |
+44 (20) 7886 2500 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
COMPANIES COVERED:
Latest directors dealings
- 17 hours ago Cerillion
- 19 hours ago Associated British Foods
- 19 hours ago B&M European Value Retail S.A. (DI)
- 19 hours ago B&M European Value Retail S.A. (DI)
- 19 hours ago Haleon